Pharmaceutical company, Chanelle Pharma, which is headquartered in Co. Galway, has appointed Pat McLoughlin as general manager.
McLoughlin has over two decades of experience in senior leadership positions in the pharmaceutical, medical device, and consumer healthcare industries.
He has previously held key roles at organisations such as B. Braun and GlaxoSmithKline.
His extensive experience includes leading global manufacturing sites, spearheading major business transformations, and advancing safety and compliance standards.
General manager
In his new role, O’Loughlin will oversee all operations across manufacturing, engineering, operating expenses or expenditure, supply chain, quality control and facilities.
Angelo Gatto, Chanelle Pharma chief executive, said that Pat brings unparalleled expertise in enhancing operational efficiency and optimising business functions.
“Pat’s outstanding leadership and proven track record in operational excellence will be key to accelerating Chanelle Pharma’s growth and transformation.
“We are thrilled to welcome him to the team and look forward to his leadership in shaping the future of our operations,” he said.
McLoughlin said that he is excited to join Chanelle Pharma “at such a pivotal time in its journey”.
“The company’s commitment to innovation and its dedication to delivering high-quality products globally is truly inspiring. I look forward to working with the talented team to build on this legacy and drive continued success,” he said.
Chanelle Pharma
Chanelle Pharma is Ireland’s largest manufacturer of generic pharmaceuticals for human and animal health.
The company employs more than 700 people across Ireland, the UK, Portugal, and Jordan.
With four manufacturing and five research and development (R&D) facilities, the company currently exports products to over 80 countries worldwide.
In February 2024, Chanelle Pharma was acquired by Exponent, a European private equity firm.